CGEM Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Neutral

43

14 3 10

Oscillators

Neutral

45

4 3 3

Moving averages

Neutral

41

10 0 7

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 6, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$1.01B

Growth and income

Eps-3.37

Free Cash Flow$-102.82M

Net Income$-49.66M

Profitability

Ebitda$-240.04M

Balance sheet

Free Cash Flow$-102.82M

Total Assets$402.98M

Total Liabilities$36.81M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

RLAYRELAY THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement VIRVIR BIOTECHNOLOGY INC+0.00%Market co-movement · Residual co-movement XNCRXENCOR INC+0.00%Market co-movement · Residual co-movement KYMRKYMERA THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement · Directional relationship NRIXNURIX THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement

RelationshipsLoading

CULLINAN THERAPEUTICS INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships